Journal of Integration Technology adheres to the principle of transparency in academic publishing and follows internationally recognized standards of publication ethics. In accordance with the guidelines issued by the Committee on Publication Ethics (COPE) and in light of the journal’s actual circumstances, the journal has formulated this Publication Ethics Statement. We require all authors, reviewers, and editors to abide by the following guidelines.
1. Author's Responsibilities
Journal of Integration Technology rigorously monitors and opposes academic misconduct, which refers to violations of academic norms and ethics. This primarily includes three categories:
• Fabrication: Inventing data without evidence.
• Falsification: Deliberately altering or misrepresenting data.
• Plagiarism: Appropriating or modifying others’ work as one’s own, whether in whole or in part, including: copying ideas, paragraphs, or entire texts, presenting others’ work with superficial modifications.
Specific manifestations of misconduct include:
• Plagiarism, fabrication, falsification.
• Improper authorship attribution.
• Duplicate submissions or publications.
• Salami publication (splitting a single study into multiple papers).
• Ethical violations in research.
Journal of Integration Technology rejects manuscripts with a similarity index exceeding 15%. For submissions below this threshold, the following criteria apply:
• Significance of duplicated content: If the duplicated sections include key results or core arguments, the manuscript will be deemed unpublishable.
• Substantive value assessment: After removing duplicated content (replaced with proper citations), the remaining material must independently support a complete academic paper. Submissions failing this test will be rejected as lacking scholarly merit.
(1) Authorship Responsibilities
Authors are accountable for the authenticity of their work and must provide supporting documents upon request, including:
• Original images/data
• Ethics approvals and informed consent forms
• Funding project documents (e.g., grant numbers, task assignments).
(2) Copyright Transfer Agreement
Submit a signed Copyright Transfer Agreement by all authors, certifying:
• No duplicate submissions
• No confidentiality issues
• No authorship disputes
• Authenticity of content and author information.
(3) “Five Prohibitions” Principle
Authors must NOT:
• Allow third-party writing or submission of manuscripts.
• Permit third-party modifications to content.
• Provide fabricated peer reviewer information.
• Violate authorship norms (see Sections 4–7).
• Include non-contributing individuals as authors.
(4) Authorship Criteria
Authors must meet all four criteria:
• Substantial contributions to research design, data acquisition, or analysis.
• Drafting or critically revising intellectual content.
• Approving the final version for publication.
• Accountability for all aspects of the work.
Individuals failing these criteria (e.g., technical assistants, funders) should be acknowledged, not listed as authors.
(5) Authorship Order
• Authors are listed by contribution, agreed upon by all co-authors at submission.
• Changes require a written request signed by all authors and approved by the editorial office.
(6) Corresponding Author
• Typically one corresponding author.
• Up to two permitted for multi-center/collaborative studies.
(7) Equal Contribution
• Designate equal contributors at submission (≤2; exceptions for large collaborations).
(8) Affiliation Requirements
• Affiliations must align with the research. If unrelated, authors must:
Clarify their role in the study.
Provide institutional proof of involvement.
(9) Institutional Attribution
• Primary affiliation is the institution where the research was conducted (e.g., for graduates, visiting scholars).
(10) Human Research Ethics
• Comply with China’s Ethical Review Measures for Biomedical Research Involving Humans (2016) and the WMA Declaration of Helsinki (2013).
• Obtain ethics approval and informed consent. If consent is unobtainable, provide ethics committee approval and justification.
• References:
http://www.gov.cn/gongbao/content/2017/content_5227817.htm
(11) Participant Privacy
• Protect participant anonymity (e.g., omit names, hospital IDs).
• Obtain consent for identifiable data and anonymize images (e.g., facial obscuration).
(12) Animal Research Ethics
• Follow Guidelines for Ethical Review of Laboratory Animal Welfare (China) and ensure humane treatment.
• Guidelines Link: http://www.lascn.com/Item/69214.aspx
(13) Clinical Trial Registration
• Register trials at WHO ICTRP (https://www.who.int/ictrp/en/) or Chinese Clinical Trial Registry (http://www.chictr.org.cn/index.aspx) and include the registration number.
(14) Conflict of Interest Declaration
• Disclose all financial interests (e.g., corporate funding, data analysis support).
(15) Appeals Process
• Submit a written appeal with point-by-point rebuttals to editorial decisions.
2. Reviewer's Responsibilities
(1) Impartial Evaluation
Reviewers must uphold academic integrity and respect academic freedom, providing honest, objective, and unbiased assessments of manuscripts. They shall not exhibit prejudice or discrimination based on the authors’ institutions, geographic location, seniority, ethnicity, or other non-academic factors, and must strictly maintain confidentiality of the manuscript’s content.
(2) Conflict of Interest Disclosure
In cases of conflict of interest (e.g., familial ties, mentor-student relationships, alumni connections, collegial affiliations, or academic competition), reviewers must promptly disclose such conflicts to the editorial office. The editorial office will determine whether recusal is necessary to ensure impartiality.
(3) Fair Treatment of Competing Work
Reviewers must not suppress or undermine manuscripts involving research areas closely aligned with their own expertise by leveraging their position as reviewers.
(4) Timeliness and Independence
• Reviewers are obligated to complete evaluations within the agreed timeframe.
• If unable to meet deadlines, reviewers must immediately notify the editorial office, withdraw from the review process, and suggest alternative reviewers.
• No delegation of review tasks to students, colleagues, or others is permitted without explicit editorial approval.
(5) Handling Previously Reviewed Manuscripts
Reviewers encountering manuscripts they have previously assessed must inform the editorial office and evaluate the work solely based on the journal’s publication criteria, regardless of prior judgments.
3. Editor's Responsibilities
(1) Adherence to Ethical Guidelines
Editors shall comply with the professional ethics of Chinese publishing professionals and the COPE Code of Conduct and Best Practices Guidelines for Journal Editors (link). They must handle manuscripts fairly, impartially, and promptly, making acceptance or rejection decisions based on the work’s significance, originality, scientific rigor, readability, authenticity, and relevance to the journal’s scope.
(2) Confidentiality
Editors must maintain strict confidentiality by:
• Protecting reviewer identities.
• Safeguarding authors’ research content during and after the review process.
(3) Independence of Peer Review
Editors shall not allow external interests to influence peer evaluations. They must ensure the independence and objectivity of the peer review process.
(4) Handling Author-Suggested Reviewers
• Verify the authenticity of suggested reviewers’ credentials.
• Assess potential conflicts of interest (e.g., shared affiliations, collaborations) before approval.
• Respect reasonable requests from authors to exclude specific reviewers.
(5) Reviewer Selection Criteria
• Avoid selecting reviewers from the same institution as the authors.
• Exclude manuscript authors from the reviewer pool.
(6) Conflict of Interest Recusal
Editors with conflicts of interest (e.g., familial, mentor-student, collegial, or competitive relationships) must recuse themselves from handling the manuscript.
(7) Appeals Process
Address author appeals seriously, either through collective editorial discussion or by requesting re-evaluation from reviewers.
(8) Publication of Negative Results
Consider publishing rigorously conducted studies with negative results to prevent redundant research efforts.
(9) Preventing Academic Misconduct
Screen all submissions and accepted manuscripts for duplicate submissions and redundant publications via two rounds of similarity checks.
(10) Authorship and Affiliation Changes
Alert authors to potential copyright or intellectual property disputes arising from changes to authorship, affiliations, or order.
(11) Transparent Feedback
Provide authors with detailed revision instructions or clear rejection reasons.
(12) Respect for Authorship
• Preserve the author’s academic voice and writing style.
• Obtain author consent for any substantive edits affecting academic arguments or conclusions.